MTX-23

N/A

Report date: 2023/02/28 18:00:26
NME

Base Information

Drug NameMTX-23
Drug Alias NameMTX-23
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degradersAndrogen receptor splice variant 7 degraders
TargetsAndrogen ReceptorAndrogen receptor splice variant 7
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMontelino Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesMontelino Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A